RxDoctor Payments Data

Ahmed Abouesh, MD

Psychiatry · Chico, CANPI 1487661120

Payments from drug & device makers

$4,721in general payments, 2019–2025

Across 261 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$954
  • Otsuka America Pharmaceutical, Inc.$703
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$475
  • Teva Pharmaceuticals USA, Inc.$418
  • Bausch Health US, LLC$330
  • Johnson & Johnson$281
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$4,711100%
  • Education$100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,721 in reported general payments places this provider in the 85th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$271,355
Medicare patients
534
Services billed
2,126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl13$16,667
Lurasidone Hcl14$7,147
Aripiprazole47$6,033
Divalproex Sodium ErDivalproex Sodium44$2,439
Olanzapine35$1,704
Quetiapine Fumarate51$1,521
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl12$1,229
Bupropion XlBupropion Hcl40$1,188
Carbamazepine14$1,074
Gabapentin106$1,019
Ventolin HfaAlbuterol Sulfate13$814
Albuterol Sulfate HfaAlbuterol Sulfate20$712
Propranolol Hcl ErPropranolol Hcl19$542
Lamotrigine54$526
Guanfacine Hcl20$512

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$954$16,66713 claims
Almatica Pharma LLCSertraline Hcl$29$21552 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Chico

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →